NASDAQ:CYNO Cynosure (CYNO) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CYNO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$66.00▼$66.0050-Day Range N/A52-Week Range$39.90▼$66.65VolumeN/AAverage Volume1.24 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cynosure alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Cynosure Stock (NASDAQ:CYNO)Cynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.Read More Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. CYNO Stock News HeadlinesApril 27, 2024 | msn.comIs Nelly Korda's Historic Effort Going In Vain? Dark Reality Buries Dominant Women's Golf NarrativeApril 27, 2024 | msn.comFans Rave About Nayanthara’s All-Black Ensemble at GQ EventApril 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 22, 2024 | msn.comSidhu serves 'justice' to Virat Kohli over no-ball row, calls out MCC for 'legalising beamer' via 3 hard-hitting pointsApril 20, 2024 | msn.comCaleb varsity founder lauds Tinubu’s education policiesApril 19, 2024 | msn.comTompolo Cynosure Still Shows, Leads 2024 Amasekumor Festival To Remarkable EndApril 19, 2024 | msn.comActors Siddharth, Aditi Rao Make Their First Public Appearance Together After EngagementApril 19, 2024 | msn.comFederation Cup: Insurance begin title defence against StormersApril 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 19, 2024 | msn.comTompolo leads 2024 Amaseikumor Festival grand finale as Ooni visitsApril 18, 2024 | msn.comKano Pillars vs Rangers headline Federation Cup round of 64 fixturesApril 18, 2024 | msn.comA new look at the original Romantic heartthrob, Lord ByronApril 18, 2024 | msn.comA new look at the original Romanic heartthrob, Lord ByronApril 17, 2024 | msn.comI Tried RF Microneedling: Here’s What You Need to KnowApril 14, 2024 | msn.comEscaping summer in Karimnagar’s serene sightsApril 13, 2024 | msn.comMS Dhoni touches World Cup trophy in emotional reunion after 13 years ahead of MI vs CSK IPL matchApril 12, 2024 | msn.comNIMASA in Blue Economy: Tinubu's brainchild-ministry promoting Nigeria's bilateral relationsApril 12, 2024 | msn.com“Wasn’t Worth”: Tony Khan’s Low Dynamite Ratings Brutally Mocked Online After CM Punk All In Footage Idea Falls FlatApril 12, 2024 | msn.comIs growth the new value? Top fund manager’s take on investing, portfolio must-haves at all-time highsApril 9, 2024 | msn.com'Sanju Samson can open for India...': Gill, Jaiswal's fresh challenge as Lara, Rayudu name 'definite T20WC frontrunners'April 8, 2024 | msn.comPreserving the legacy of chess in KolkataApril 7, 2024 | msn.comIPL 2024: Would GT be able to capitalise Mayank`s pace?April 6, 2024 | msn.comDC vs MI Dream11 Predictions: Delhi Capitals vs Mumbai Indians Playing 11 Updates & Fantasy Picks DetailsApril 6, 2024 | msn.comIPL 2024: Fit-again Suryakumar expected to rescue struggling MIApril 6, 2024 | msn.comChristian Coleman Would Never Have Become the Fastest Man if Not for This AmbitionApril 4, 2024 | msn.comAbiola Makinde lays foundation for movie village in OndoApril 4, 2024 | msn.comPraggnanandhaa to meet Firouza in the opener; Gukesh to clash with ViditSee More Headlines Receive CYNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cynosure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/26/2016Today4/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CYNO CUSIP23257720 CIK885306 Webwww.cynosure.com Phone+1-978-2564200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report CYNO Stock Analysis - Frequently Asked Questions How were Cynosure's earnings last quarter? Cynosure, Inc. (NASDAQ:CYNO) released its quarterly earnings data on Tuesday, July, 26th. The medical equipment provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.07. The medical equipment provider earned $110.30 million during the quarter, compared to the consensus estimate of $101.31 million. The business's revenue was up 31.8% compared to the same quarter last year. During the same period last year, the company posted $0.30 earnings per share. What other stocks do shareholders of Cynosure own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), Xtrackers California Municipal Bond ETF (CA), Golar LNG Partners (GMLP), Micron Technology (MU), Endologix (ELGX), BlackRock (BLK) and Chipotle Mexican Grill (CMG). This page (NASDAQ:CYNO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cynosure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.